We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A developing framework through which the CDEI is analysing the governance of data-driven technology in the context of its work programme.
First published during the 2019 to 2022 Johnson Conservative government
Employment Tribunal decision.
First published during the 2016 to 2019 May Conservative government
Statement by Ambassador James Kariuki at the UN Security Council meeting on peace through dialogue.
First published during the 2022 to 2024 Sunak Conservative government
New research on barriers and enablers in the transition to net zero for fuel poor, and the customer journey during the delivery of energy efficiency programmes.
Reforms to occupational health services will be shaped through a £1.5m innovation fund, through Innovate UK's Small Business Research Initiative (SBRI), as the government continues its drive to tackle in work sickness and boost economic activity using new technology and...
Rishi Sunak reflects on his first year as Prime Minister.
Scenario thinking is a strategic planning method that organisations use to make flexible long-term plans
This report examines the changing nature of participation through social media
Product recall for a LUKAT Baby Toys for 3 4 5 Year Old Boys & Girls, 4 in 1 Activity Cube Toddler Multifunctional Play Center with Ramp Track Musical Educational Toys presenting a high risk of choking.
Patients with a certain type of advanced or spreading non-small cell lung cancer (NSCLC) could access a new cancer therapy to help treat their condition.
There is a risk of harmful drug interactions with the ritonavir component of the COVID-19 treatment Paxlovid▼ due to its inhibition of the enzyme CYP3A, which metabolises many commonly used drugs. Prescribers should obtain a detailed patient history of current...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).